Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 450 of 593 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/25/02
End: 11/15/07
Due: 11/15/08
Phase: N/A
Priority: Normal
Start: 02/01/07
End: 12/24/08
Due: 12/24/09
Phase: N/A
Priority: Normal
Start: 12/31/00
End: 11/30/02
Due: 11/30/03
Phase: N/A
Priority: Normal
Start: 06/30/96
End: 06/30/00
Due: 06/30/01
Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
Phase: N/A
Priority: Normal
Start: 03/27/25
End: 09/01/27
Due: 09/01/28
Phase: N/A
Priority: Normal
Start: 11/30/01
End: 04/30/03
Due: 04/30/04
Phase: N/A
Priority: Normal
Start: 02/11/02
End: 02/03/15
Due: 02/03/16
Phase: N/A
Priority: Normal
Start: 12/31/01
End: 03/31/04
Due: 03/31/05
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 01/02/22
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 01/14/07
End: 12/20/19
Due: 12/20/20
Phase: N/A
Priority: Normal
Start: 02/11/02
End: 12/28/07
Due: 12/28/08
Phase: N/A
Priority: Normal
Start: 07/08/05
End: 06/25/07
Due: 06/25/08
Phase: N/A
Priority: Normal
Start: 01/31/02
End: 02/28/03
Due: 02/28/04
Phase: N/A
Priority: Normal
Start: 09/30/94
End: 08/31/02
Due: 08/31/03
Phase: N/A
Priority: Normal
Start: 02/04/05
End: 05/10/11
Due: 05/10/12
Phase: N/A
Priority: Normal
Start: 05/16/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/01
End: 08/31/03
Due: 08/31/04
Phase: N/A
Priority: Normal
Start: 10/01/03
End: 05/09/18
Due: 05/09/19
Phase: N/A
Priority: Normal
Start: 12/11/12
End: 07/23/15
Due: 07/23/16
Phase: N/A
Priority: Normal
Start: 09/09/97
End: 12/15/08
Due: 12/15/09
Phase: N/A
Priority: Normal
Start: 04/21/15
End: 10/30/17
Due: 10/30/18
Phase: N/A
Priority: Normal
Start: 05/05/06
End: 05/20/08
Due: 05/20/09
Phase: N/A
Priority: Normal
Start: 10/18/06
End: 07/18/08
Due: 07/18/09
Phase: N/A
Priority: Normal
Start: 02/24/20
End: 11/02/21
Due: 11/02/22